Bruker Corp. (NASDAQ:BRKR)

CAPS Rating: 3 out of 5

The Company designs, manufactures, services and markets analytical and life science systems and associated products to address the needs of its customers in life science research, pharmaceutical, biotechnology and molecular diagnostics research.

Recs

0
Player Avatar OklaBoston (68.30) Submitted: 12/23/2012 4:08:00 AM : Outperform Start Price: $16.82 BRKR Score: -10.57

CEO Open market buying, a high rating from StockScouter, and some bullish charts, in basically that order.

Featured Broker Partners


Advertisement